Oncolytics Biotech Inc (ONCY)
1.17
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
1.17
0.00 (0.00%)
After-Hours: 20:00
Oncolytics Biotech 1 Year Total Returns (Daily): -27.78% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -27.78% |
May 02, 2024 | -32.76% |
May 01, 2024 | -29.56% |
April 30, 2024 | -23.97% |
April 29, 2024 | -25.34% |
April 26, 2024 | -14.17% |
April 25, 2024 | -4.42% |
April 24, 2024 | -6.19% |
April 23, 2024 | -9.40% |
April 22, 2024 | -11.11% |
April 19, 2024 | -8.62% |
April 18, 2024 | -10.43% |
April 17, 2024 | -7.14% |
April 16, 2024 | -6.09% |
April 15, 2024 | -7.83% |
April 12, 2024 | 0.88% |
April 11, 2024 | 1.00% |
April 10, 2024 | 1.80% |
April 09, 2024 | 0.87% |
April 08, 2024 | 0.87% |
April 05, 2024 | 0.00% |
April 04, 2024 | 1.32% |
April 03, 2024 | -7.56% |
April 02, 2024 | -10.83% |
April 01, 2024 | -11.67% |
Date | Value |
---|---|
March 28, 2024 | -12.40% |
March 27, 2024 | -16.60% |
March 26, 2024 | -16.53% |
March 25, 2024 | -14.88% |
March 22, 2024 | -18.03% |
March 21, 2024 | -18.90% |
March 20, 2024 | -21.71% |
March 19, 2024 | -23.70% |
March 18, 2024 | -22.96% |
March 15, 2024 | -25.65% |
March 14, 2024 | -21.54% |
March 13, 2024 | -16.13% |
March 12, 2024 | -14.52% |
March 11, 2024 | -14.52% |
March 08, 2024 | -25.00% |
March 07, 2024 | -30.67% |
March 06, 2024 | -33.33% |
March 05, 2024 | -35.22% |
March 04, 2024 | -42.14% |
March 01, 2024 | -26.80% |
February 29, 2024 | -25.49% |
February 28, 2024 | -33.33% |
February 27, 2024 | -31.58% |
February 26, 2024 | -37.74% |
February 23, 2024 | -39.08% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.87%
Minimum
Oct 02 2019
391.9%
Maximum
Oct 14 2020
13.77%
Average
-5.26%
Median
Dec 17 2019
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | 10.17% |
Aurinia Pharmaceuticals Inc | -56.37% |
Edesa Biotech Inc | -40.91% |
Lexaria Bioscience Corp | 93.21% |
Xenon Pharmaceuticals Inc | 7.28% |